Evidence map›Paper›PMID 36385678›Full record

ArticleImmunologic research2023

Interplay between C1-inhibitor and group IIA secreted phospholipase A

Anne Lise Ferrara, Maria Bova, Angelica Petraroli, Daniela Marasco, Christine Payré, Sara Fortuna, Francesco Palestra, Renato Ciardi, Gianni Marone, Giuseppe Spadaro and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunologic research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Anne Lise FerraraDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Maria BovaDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Angelica PetraroliDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Daniela MarascoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy.
Christine PayréInstitut de Pharmacologie Moléculaire Et Cellulaire, CNRS, Université Côte d'Azur, Valbonne Sophia Antipolis, Nice, France.
Sara FortunaIstituto Italiano Di Tecnologia (IIT), Via E. Melen, 83, 16152, Genoa, Italy.
Francesco PalestraDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Renato CiardiDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Gianni MaroneDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Giuseppe SpadaroDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Gérard LambeauInstitut de Pharmacologie Moléculaire Et Cellulaire, CNRS, Université Côte d'Azur, Valbonne Sophia Antipolis, Nice, France.
Stefania LoffredoDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy. stefanialoffredo@hotmail.com.ORCID 0000-0002-5871-1898
University of Naples Federico II · ITCentre National de la Recherche Scientifique · FRInstitute for Experimental Endocrinology and Oncology · ITFatebenefratelli Hospital · ITFederico II University Hospital · ITItalian Institute of Technology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High levels of human group IIA secreted phospholipase A

Indexed as

Angioedemas, HereditaryComplement C1 Inhibitor ProteinGroup II Phospholipases A2HumansInterleukin-6Leukocytes, MononuclearMolecular Docking SimulationTumor Necrosis Factor-alphaComplement C1 Inhibitor ProteinGroup II Phospholipases A2Interleukin-6SERPING1 protein, humanTumor Necrosis Factor-alphaAngioedemaBlood mononuclear cellsC1-INHChemokinesCytokinesPhospholipase A2

Identifiers

PMID36385678
PMCPMC9845149
OpenAlexW4309246688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.